Uninsured Rates Among Minorities Took A Nosedive Under The ACA
Research out from the Department of 国产精品视频 and Human Services Friday points toward an impact of the Affordable Care Act on minority groups in the U.S: There was an increase in the number of those with health insurance between 2010 and 2022. In other news, Former President Donald Trump tries to take credit for insulin pricing.
Uninsured rates among minority groups in the U.S. plunged between 2010 and 2022, according to reports released Friday by the U.S. Department of 国产精品视频 and Human Services (HHS). The increase in the number of insured people points to the impact of the Affordable Care Act, former President Obama鈥檚 signature health law. (Maher, 6/7)
Meanwhile 鈥
Former President Trump attempted to take credit for insulin pricing in a Saturday post on Truth Social. 鈥淟ow INSULIN PRICING was gotten for millions of Americans by me, and the Trump Administration, not by Crooked [President Biden,]鈥 Trump said in the Truth Social post. 鈥淗e had NOTHING to do with it. It was all done long before he so sadly entered office. All he does is try to take credit for things done by others, in this case, ME!鈥 (Suter, 6/8)
鈥淒onald Trump is now saying he, not Joe Biden, reduced the cost of insulin. How can you be so bold with your lies? If this guy didn鈥檛 do a single thing, but the push to reduce, in fact, eliminate the Affordable Care Act? In fact, he used that as his reason for being against John McCain and mimic him for having cast the deciding vote, not to eliminate the Affordable Care Act,鈥 Clyburn said. (Sforza, 6/9)
Trump鈥檚 new anti-vaccine persona could have far-reaching consequences if he鈥檚 elected to a second stint as president with far-reaching administrative powers. Public health experts say a White House opposed to immunization mandates could potentially cause upticks in cases of measles, polio and other vaccine-preventable diseases, or hamper efforts to fight a future pandemic. The CDC could pare back the number of vaccines it recommends children receive or eliminate those recommendations entirely. (Messerly, 6/9)
Democrats have hit on a new tactic in their long battle with drug companies: challenge patents that they say are deliberate attempts to game the system and box out low-cost, generic competitors. ... The Democrats are targeting Novo Nordisk, including some of its patents related to expensive drug Ozempic; GlaxoSmithKline; and other companies that produce asthma and diabetes medications. (Diamond, 6/7)
A federal judge Friday denied a motion by the聽federal government to dismiss聽a legal challenge seeking to block updated聽Medicare Advantage auditing standards. Humana, the second-largest Medicare Advantage insurer by membership, sued the 国产精品视频 and Human Services Department in September 2023 over a regulation announced by the Centers for Medicare and Medicaid Services earlier that year. (Tepper, 6/7)
In other administration news 鈥
The National Institutes of 国产精品视频 is piloting a cross-country network for primary care research to improve community-based primary care and increase the presence of underserved populations in clinical research, the agency announced Thursday. As part of the Communities Advancing Research Equity for 国产精品视频 initiative, also known as CARE for 国产精品视频, NIH-funded clinical research networks and primary care sites will partner to conduct studies and research on health issues affecting local patient populations. (Devereaux, 6/7)
The U.S. Food and Drug Administration approved the expanded use of GSK's (GSK.L) respiratory syncytial virus (RSV) vaccine on Friday in adults aged between 50 and 59, making it the first shot endorsed for that age group. The shot, branded Arexvy, and vaccines from rivals Pfizer (PFE.N) and Moderna (MRNA.O) are already approved for people aged 60 and older for the virus. RSV is a leading cause of pneumonia ... causing 177,000 hospitalizations and 14,000 deaths in the United States annually. (Roy and Santhosh, 6/8)
The outlook for the latest experimental drug shown to delay Alzheimer's disease will come into focus Monday, when Food and Drug Administration advisers review an application from Eli Lilly that's been held up by questions about the design of clinical trials and safety risks. Their conclusions could influence how the FDA treats future drugs that target proteins in the brain known as amyloid plaques that are believed to contribute to the development of the dreaded neurological condition that afflicts nearly 7 million people in the U.S. (Bettelheim, 6/10)
Five Texas farmers and ranchers are suing EPA over its failure to limit "forever chemicals" in sludge, a problem that they say has killed their animals, jeopardized their health and devalued their land. The complaint, filed Thursday in the U.S. District Court for the District of Columbia, comes while EPA assesses the risks of two types of PFAS, or per- and polyfluoroalkyl substances, in biosolids, a term for sewage sludge treated to be used as fertilizer. (Borst, 6/7)